BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.500
-0.100 (-6.25%)
Jun 4, 2026, 11:50 AM IDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of 41.94 million as of June 3, 2026. Its market cap has decreased by -1.14% in one year.
Market Cap
41.94M
Enterprise Value
28.92M
Revenue
4.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.50
Market Cap Chart
Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 41.94M, an increase of 25,623.44%. That is a compound annual growth rate of 33.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 41.94M | 0.39% |
| Dec 31, 2025 | 41.77M | -51.17% |
| Dec 31, 2024 | 85.55M | -79.39% |
| Dec 31, 2023 | 415.08M | 314.57% |
| Dec 29, 2022 | 100.12M | -67.59% |
| Dec 30, 2021 | 308.95M | 60.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 438.05M |
| Geffen Residence & Renewal | 321.70M |
| Matricelf | 80.83M |
| Clal Biotechnology Industries | 43.45M |
| BioLight Life Sciences | 28.55M |
| Can-Fite BioPharma | 19.33M |
| Purple Biotech | 18.65M |
| Evogene | 17.07M |